Vanda Pharmaceuticals, Inc. (VNDA)

6.84 -0.19 (-2.70%) USD  |  NASDAQ  |  Dec 23, 16:00
6.94 +0.10 (+1.46%) Pre-Market: 08:53
More

Vanda Pharmaceuticals SG&A Expense (TTM): 214.26M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for VNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 523.36M
ADMA Biologics, Inc. 96.37M
Aldeyra Therapeutics, Inc. 9.186M
Exelixis, Inc. 530.03M
AnaptysBio, Inc. 45.14M